MedPage Today interviewed Nicholas Brownstone, MD, a dermatology resident at Temple University Hospital, for two articles about psoriasis – one on comorbidities and one on new targeted molecular agents for treatment.
Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.
Learn MoreMedPage Today interviewed Nicholas Brownstone, MD, a dermatology resident at Temple University Hospital, for two articles about psoriasis – one on comorbidities and one on new targeted molecular agents for treatment.